Rapid diagnosis of cervical cancer based on serum FTIR spectroscopy and support vector machines
- PMID: 38001244
- DOI: 10.1007/s10103-023-03930-y
Rapid diagnosis of cervical cancer based on serum FTIR spectroscopy and support vector machines
Abstract
Cervical cancer is one of the most common malignant tumors among female gynecological diseases. This paper aims to explore the feasibility of utilizing serum Fourier Transform Infrared (FTIR) spectroscopy, combined with machine learning and deep learning algorithms, to efficiently differentiate between healthy individuals, hysteromyoma patients, and cervical cancer patients. In this study, serum samples from 30 groups of hysteromyoma, 36 groups of cervical cancer, and 30 healthy groups were collected and FTIR spectra of each group were recorded. In addition, the raw datasets were averaged according to the number of scans to obtain an average dataset, and the raw datasets were spectrally enhanced to obtain an augmentation dataset, resulting in a total of three sets of data with sizes of 258, 96, and 1806, respectively. Then, the hyperparameters in the four kernel functions of the Support Vector Machine (SVM) model were optimized by grid search and leave-one-out (LOO) cross-validation. The resulting SVM models achieved recognition accuracies ranging from 85.0% to 100.0% on the test set. Furthermore, a one-dimensional convolutional neural network (1D-CNN) demonstrated a recognition accuracy of 75.0% to 90.0% on the test set. It can be concluded that the use of serum FTIR spectroscopy combined with the SVM algorithm for the diagnosis of cervical cancer has important medical significance.
Keywords: Cervical cancer; Diagnosis; FTIR spectroscopy; Machine learning; Parameters optimization; Serum.
© 2023. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.
Similar articles
-
Application of Fourier Transform InfraRed spectroscopy of machine learning with Support Vector Machine and principal components analysis to detect biochemical changes in dried serum of patients with primary myelofibrosis.Biochim Biophys Acta Gen Subj. 2023 Oct;1867(10):130438. doi: 10.1016/j.bbagen.2023.130438. Epub 2023 Jul 27. Biochim Biophys Acta Gen Subj. 2023. PMID: 37516257
-
Fourier transform InfraRed spectra analyzed by multivariate and machine learning methods in determination spectroscopy marker of prostate cancer in dried serum.Spectrochim Acta A Mol Biomol Spectrosc. 2025 Feb 15;327:125305. doi: 10.1016/j.saa.2024.125305. Epub 2024 Oct 22. Spectrochim Acta A Mol Biomol Spectrosc. 2025. PMID: 39490177
-
Compared between support vector machine (SVM) and deep belief network (DBN) for multi-classification of Raman spectroscopy for cervical diseases.Photodiagnosis Photodyn Ther. 2023 Jun;42:103340. doi: 10.1016/j.pdpdt.2023.103340. Epub 2023 Feb 27. Photodiagnosis Photodyn Ther. 2023. PMID: 36858147
-
A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.Comput Methods Programs Biomed. 2018 Oct;164:15-22. doi: 10.1016/j.cmpb.2018.05.034. Epub 2018 Jun 26. Comput Methods Programs Biomed. 2018. PMID: 30195423 Review.
-
Cervical cancer survival prediction by machine learning algorithms: a systematic review.BMC Cancer. 2023 Apr 13;23(1):341. doi: 10.1186/s12885-023-10808-3. BMC Cancer. 2023. PMID: 37055741 Free PMC article.
Cited by
-
Machine and Deep Learning for the Diagnosis, Prognosis, and Treatment of Cervical Cancer: A Scoping Review.Diagnostics (Basel). 2025 Jun 17;15(12):1543. doi: 10.3390/diagnostics15121543. Diagnostics (Basel). 2025. PMID: 40564863 Free PMC article. Review.
References
-
- Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical cancer. The Lancet 393(10167):169–182 - DOI
-
- Marashi T, Irandoost SF, Yoosefi Lebni J, Soofizad G (2021) Exploring the barriers to pap smear test in Iranian women: a qualitative study. BMC Women’s Health 21(1):1–12 - DOI
-
- Liang LA, Einzmann T, Franzen A, Schwarzer K, Schauberger G, Schriefer D, Radde K, Zeissig SR, Ikenberg H, Meijer CJ et al (2021) Cervical cancer screening: comparison of conventional pap smear test, liquid-based cytology, and human papillomavirus testing as stand-alone or cotesting strategies comparing cervical cancer screening strategies. Cancer Epidemiology, Biomarkers & Prevention 30(3):474–484 - DOI